Form 8-K - Current report:
SEC Accession No. 0001213900-14-000096
Filing Date
2014-01-08
Accepted
2014-01-08 17:23:46
Documents
23
Period of Report
2014-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRET REPORT f8k010814_immudyne.htm 8-K 22739
2 IMMUDYNE, INC. CORPORATE PRESENTATION f8k010814ex99i_immudyne.htm EX-99.1 18746
3 slide1.jpg GRAPHIC 37274
4 slide2.jpg GRAPHIC 139592
5 slide3.jpg GRAPHIC 76506
6 slide4i.jpg GRAPHIC 107993
7 slide5.jpg GRAPHIC 103940
8 slide6.jpg GRAPHIC 39446
9 slide7.jpg GRAPHIC 101466
10 slide8.jpg GRAPHIC 102582
11 slide9.jpg GRAPHIC 51151
12 slide10.jpg GRAPHIC 94224
13 slide11.jpg GRAPHIC 59806
14 slide12.jpg GRAPHIC 62901
15 slide13.jpg GRAPHIC 87626
16 slide14.jpg GRAPHIC 97033
17 slide15i.jpg GRAPHIC 104925
18 slide16.jpg GRAPHIC 29489
19 slide17.jpg GRAPHIC 99252
20 slide18.jpg GRAPHIC 103858
21 slide19.jpg GRAPHIC 81428
22 slide20.jpg GRAPHIC 72706
23 slide21.jpg GRAPHIC 93854
  Complete submission text file 0001213900-14-000096.txt   2452145
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-184487 | Film No.: 14517143
SIC: 2833 Medicinal Chemicals & Botanical Products